Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Non-interventional, Observational Study of Treatment and Biomarker Testing Patterns, Treatment Outcomes in Advanced/Metastatic NSCLC With and Without Actionable Genomic Alterations in Routine Clinical Practice in Russia

NCT06245837 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06245837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06245837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Non-interventional, Observational Study of Treatment and Biomarker Testing Patterns, Treatment Outcomes in Advanced/Metastatic NSCLC With and Without Actionable Genomic Alterations in Routine Clinical Practice in Russia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
March 20, 2024
Completion date
June 30, 2026
Enrollment
1,500 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer